Pegylated liposomal doxorubicin and vinorelbine in metastatic breast cancer: Final results of a phase II trial

被引：0
|
作者：
Elsaid, A. A.
Awad, N. M.
机构：
[1] Univ Alexandria, Fac Med, Alexandria, Egypt
[2] Univ Alexandria, Alexandria, Egypt
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e11050
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11050
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial of vinorelbine and pegylated liposomal doxorubicin in patients with pretreated metastatic breast cancer
    Chow, Louis Wing-Cheong
    Yip, Adrian Yun-San
    Lang, Brian Hung-Hin
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (02): : 133 - 138
  • [2] Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial
    Schmid, Peter
    Krocker, J.
    Kreienberg, R.
    Klare, P.
    Kittel, K.
    Sommer, H.
    Heinrich, G.
    Steck, T.
    Lichtenegger, W.
    Elling, D.
    Kuemmel, S.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 401 - 406
  • [3] Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial
    Peter Schmid
    J. Krocker
    R. Kreienberg
    P. Klare
    K. Kittel
    H. Sommer
    G. Heinrich
    T. Steck
    W. Lichtenegger
    D. Elling
    S. Kümmel
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 64 : 401 - 406
  • [4] Phase I trial of pegylated liposomal doxorubicin and lapatinib in the treatment of metastatic breast cancer (MBC): Final results
    Cianfrocca, Mary E.
    Kaklamani, Virginia G.
    Rosen, Steven T.
    Von Roenn, Jamie H.
    Rademaker, Alfred
    Smith, Deborah A.
    Rubin, Stephen D.
    Meservey, Caitlin
    Uthe, Regina
    Gradishar, William John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients
    Jacquin, Jean-Philippe
    Chargari, Cyrus
    Thorin, Julie
    Mille, Dominique
    Melis, Adrien
    Orfeuvre, Hubert
    Clavreul, Guillaume
    Chaigneau, Loic
    Nourissat, Alice
    Dumanoir, Chantal
    Savary, Jacqueline
    Merrouche, Yacine
    Magne, Nicolas
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (01): : 18 - 21
  • [6] Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer
    Chang, Amy E.
    Wu, Qian V.
    Jenkins, Isaac C.
    Specht, Jennifer M.
    Gadi, Vijayakrishna K.
    Gralow, Julie R.
    Salazar, Lupe G.
    Kurland, Brenda F.
    Linden, Hannah M.
    [J]. CLINICAL BREAST CANCER, 2018, 18 (01) : E143 - E149
  • [7] Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma - A phase I-II clinical investigation
    Gebbia, V
    Mauceri, G
    Fallica, G
    Borsellino, N
    Tirrito, ML
    Testa, A
    Varvara, F
    Colombo, A
    Ferrera, P
    [J]. ONCOLOGY, 2002, 63 (01) : 23 - 30
  • [8] Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer
    Irvin, William J., Jr.
    Orlowski, Robert Z.
    Chiu, Wing-Keung
    Carey, Lisa A.
    Collichio, Frances A.
    Bernard, Philip S.
    Stijleman, Inge J.
    Perou, Charles
    Ivanova, Anastasia
    Dees, E. Claire
    [J]. CLINICAL BREAST CANCER, 2010, 10 (06) : 465 - 470
  • [9] Pegylated liposomal doxorubicin in previously treated patients with metastatic breast cancer - a large multicenter phase II trial
    Al-Batran, SE
    Bischoff, J
    von Minckwitz, G
    Atmaca, A
    Kleeberg, U
    Meuthen, I
    Morack, G
    Lerbs, W
    Hccker, D
    Jager, E
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S280 - S280
  • [10] A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
    Huober, Jens
    Fett, Werner
    Nusch, Arnd
    Neise, Michael
    Schmidt, Marcus
    Wischnik, Arthur
    Gerhardt, Steffen
    Goehler, Thomas
    Lueck, Hans-Joachim
    Rost, Andreas
    [J]. BMC CANCER, 2010, 10
12345